SEC Filing Details
Document Details
Form
Filing Date
Jul 15, 2026
Document Date
Jul 13, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Fulcrum Therapeutics
Issuer
Fulcrum Therapeutics, Inc.
Filer
TANG KEVIN